A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients

Comment

Stefano Crippa et al. Ann Surg. 2007 May.

. 2007 May;245(5):826-7; author reply 527-8.

doi: 10.1097/01.sla.0000261153.24610.ec.

No abstract available

Comment on

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.
Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF. Allen PJ, et al. Ann Surg. 2006 Oct;244(4):572-82. doi: 10.1097/01.sla.0000237652.84466.54. Ann Surg. 2006. PMID: 16998366 Free PMC article.

1. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–685. - PMC - PubMed
1. Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005;242:413–419. - PMC - PubMed
1. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–797. - PMC - PubMed
1. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410–422. - PubMed
1. Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg. 2000;231:205–212. - PMC - PubMed